| Aetna | Cataract Surgery | 2026-06-02 |
| Aetna | Genetic Testing | 2026-06-01 |
| Aetna | Vascular Endothelial Growth Factor Inhibitors for Ocular Indications | 2026-06-01 |
| UHC UMR Medical and Drug | Ambulance Services – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC UMR Medical and Drug | Breast Reduction Surgery – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC UMR Medical and Drug | Catheter Ablation for Atrial Fibrillation – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC UMR Medical and Drug | Cell-Free Fetal DNA Testing – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC UMR Medical and Drug | Chromosome Microarray Testing (Non-Oncology Conditions) – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC UMR Medical and Drug | Cochlear Implants – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC UMR Medical and Drug | Cosentyx® (Secukinumab) – Commercial Medical Benefit Drug Policy | 2026-06-01 |